Synta Pharmaceuticals Corp. (SNTA)

[Cramerica]

You still might get .15 idk why everybody is acting like positive data was just released.

From what I understand Galaxy 2 was a form of Ganetespib intended to target tumor cells on the glandular structures of the lungs and in this trial Ganetespib will be attempting to target tumor cells near the surface of the lungs. I'm not a pharmacist with extensive knowledge on the mechanism of action of Ganetespib but I just don't see how a drug with a similar profile of Galaxy 2 will suddenly be more effective against a similar type of cancer.

Alternately there are still 4+ trials remaining and
before the board crucifies me, I still think its inevitable we see some good news from at least one.

Apologies if some of that sounds pessimistic, but I like to think of the risk more than the reward.